Murphy H R, Harris H W
Laboratory of Kidney and Electrolyte Metabolism, National Heart, Lung and Blood Institute, Bethesda, Maryland 20982.
Anal Biochem. 1987 Aug 15;165(1):88-95. doi: 10.1016/0003-2697(87)90204-1.
J. B. Denny and G. Blobel (1984, Proc, Natl. Acad. Sci. USA 81, 5286-5290) have described the synthesis of a water-soluble novel heterobifunctional 125I-labeled photocrosslinking reagent, N-[4-(p-azido-m-[125I]iodophenylazo)benzoyl]-3-aminopropionyl-N'- oxysulfosuccinimide, which contains a cleavable internal azo bond. We report several modifications of their synthesis which greatly increase the yield of a synthetic intermediate, N-[4-(p-aminophenylazo)benzoyl]-3-aminopropionic acid (compound VII). Evidence is presented that direct iodination of compound VII with chloramine-T produces low yields of 125I-labeled compound VII in a reaction which is difficult to control. Alternatively, the yield of 125I-labeled reagent can be greatly improved if the iodination is performed following the derivatization of N-[4-(p-axidophenylazo)benzoyl]-3-aminopropionyl-N'-oxysulfosuc cinimide (compound IX) to a ligand such as dextran. We have demonstrated the transfer of 125I label from the reagent when derivatized to amino-dextran to proteins in solution after photolysis and cleavage of this 125I-labeled reagent.
J. B. 丹尼和G. 布洛贝尔(1984年,《美国国家科学院院刊》81卷,5286 - 5290页)描述了一种水溶性新型异双功能125I标记的光交联试剂N - [4 - (对叠氮基 - 间 - [125I]碘苯基偶氮)苯甲酰基] - 3 - 氨基丙酰基 - N'-氧代磺基琥珀酰亚胺的合成,该试剂含有一个可裂解的内部偶氮键。我们报告了对其合成方法的几种改进,这些改进极大地提高了合成中间体N - [4 - (对氨基苯基偶氮)苯甲酰基] - 3 - 氨基丙酸(化合物VII)的产率。有证据表明,用氯胺 - T对化合物VII进行直接碘化时,在一个难以控制的反应中,125I标记的化合物VII产率很低。另外,如果在将N - [4 - (对叠氮基苯基偶氮)苯甲酰基] - 3 - 氨基丙酰基 - N'-氧代磺基琥珀酰亚胺(化合物IX)衍生化为诸如葡聚糖等配体之后进行碘化,125I标记试剂的产率可以大大提高。我们已经证明,在光解和裂解这种125I标记试剂后,当该试剂衍生化为氨基葡聚糖时,125I标记能从试剂转移到溶液中的蛋白质上。